| MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma MJM Van Velzen, S Derks, NCT Van Grieken, NH Mohammad, ... Cancer treatment reviews 86, 102024, 2020 | 109 | 2020 |
| Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer MJM van Velzen, A Creemers, T van den Ende, S Schokker, S Krausz, ... Gastric Cancer 25 (5), 906-915, 2022 | 16 | 2022 |
| Apparent ‘JAK2-negative’polycythaemia vera due to compound mutations in exon 14 IS Tiong, DA Casolari, S Moore, T Nguyen, MJ Van Velzen, D Zantomio, ... Br J Haematol 178 (2), 333-336, 2017 | 16 | 2017 |
| The association between effectiveness of first-line treatment and second-line treatment in gastro-oesophageal cancer MJM van Velzen, M Pape, WPM Dijksterhuis, M Slingerland, ... European Journal of Cancer 156, 60-69, 2021 | 5 | 2021 |
| Short-term fasting and fasting mimicking diets combined with chemotherapy: a narrative review J Kikomeko, T Schutte, MJM van Velzen, R Seefat, HWM van Laarhoven Therapeutic advances in medical oncology 15, 17588359231161418, 2023 | 4 | 2023 |
| Masked polycythaemia vera is genetically intermediate between JAK2V617F mutated essential thrombocythaemia and overt polycythaemia vera IS Tiong, DA Casolari, T Nguyen, MJM Van Velzen, K Ambler, ... Blood Cancer Journal 6 (8), e459-e459, 2016 | 4 | 2016 |
| Incidence, Stage, Treatment, and Survival of Noncardia Gastric Cancer MJM van Velzen, M Braemer, GAP Nieuwenhuijzen, JW van Sandick, ... JAMA Network Open 6 (8), e2330018-e2330018, 2023 | 3 | 2023 |
| Exercise and Nutritional Interventions in Patients with Advanced Gastroesophageal Cancer: A Systematic Review J Besseling, M van Velzen, N Wierdsma, KS Alonso-Duin, P Weijs, ... Journal of gastrointestinal cancer 54 (3), 1006-1009, 2023 | 1 | 2023 |
| Chemotherapy-induced neuropathy in esophagogastric cancer. M van Velzen, M Pape, JJ van Kleef, M Slingerland, LV Beerepoot, ... Journal of Clinical Oncology 41 (4_suppl), 309-309, 2023 | | 2023 |
